Kin Man Au

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Transforming Growth Factor

Hodgkin Lymphoma

Ulcerative Colitis

Top Venues

Advanced materials (Deerfield Beach, Fla.)

Nature biomedical engineering

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kin Man Au, Yuanzeng Min, Xi Tian, Longzhen Zhang, Virginia Perello, Joseph M Caster, Andrew Z Wang
Correction to "Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles". ACS nano (2024)
Kin Man Au, Justin E Wilson, Jenny P-Y Ting, Andrew Z Wang
Author Correction: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature biomedical engineering (2024)
Kin Man Au, Roland Tisch, Andrew Wang
Correction to Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis. Advanced materials (Deerfield Beach, Fla.) 36 (31) (2024)
Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin, Kyle Wagner, Seungpyo Hong, Andrew Z Wang, Steven I Park
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma". ACS nano 18 (23) (2024)
Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin, Kyle Wagner, Seungpyo Hong, Andrew Z Wang, Steven I Park
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma". ACS nano (2024)
Kin Man Au, Yuanzeng Min, Xi Tian, Longzhen Zhang, Virginia Perello, Joseph M Caster, Andrew Z Wang
Correction to "Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles". ACS nano 18 (21) (2024)
Kin Man Au, Rod Balhorn, Monique C Balhorn, Steven I Park, Andrew Z Wang
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles". ACS central science 10 (5) (2024)
Kin Man Au, Roland Tisch, Andrew Wang
Correction to Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis. Advanced materials (Deerfield Beach, Fla.) (2024)
Kin Man Au, Justin E Wilson, Jenny P-Y Ting, Andrew Z Wang
Author Correction: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature biomedical engineering (2024)
Kin Man Au, Justin E Wilson, Jenny P-Y Ting, Andrew Z Wang
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature biomedical engineering (2023)
Kin Man Au, Yusra Medik, Qi Ke, Roland Tisch, Andrew Z Wang
Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes. Advanced materials (Deerfield Beach, Fla.) 33 (25) (2021)
Kin Man Au, Roland Tisch, Andrew Z Wang
In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus. ACS nano (2021)
Kin Man Au, Roland Tisch, Andrew Z Wang
Immune Checkpoint Ligand-Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis. Advanced materials (Deerfield Beach, Fla.) (2021)
Kin Man Au, Andrew Z Wang, Steven I Park
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma. Science advances 6 (14) (2020)
Kin Man Au, Steven I Park, Andrew Z Wang
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy. Science advances 6 (27) (2020)
Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin, Kyle Wagner, Seungpyo Hong, Andrew Z Wang, Steven I Park
Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS nano 12 (2) (2018)